Schedule 13G ownership disclosure

CANCER GENETICS INC.

Security class unavailable · CUSIP: 13739U104

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
833,300
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-16-004880
Form type
SC 13G/A
Filer
Vyant Bio, Inc.
CIK
CIK 1349929
Filed
Jan 19, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub